0001493152-22-026229.txt : 20220919 0001493152-22-026229.hdr.sgml : 20220919 20220919160528 ACCESSION NUMBER: 0001493152-22-026229 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220919 DATE AS OF CHANGE: 20220919 EFFECTIVENESS DATE: 20220919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REVIVA PHARMACEUTICALS HOLDINGS, INC. CENTRAL INDEX KEY: 0001742927 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-459214 FILM NUMBER: 221250670 BUSINESS ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. STREET 2: SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 4085018881 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. STREET 2: SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: Tenzing Acquisition Corp. DATE OF NAME CHANGE: 20180606 D 1 primary_doc.xml X0708 D LIVE 0001742927 REVIVA PHARMACEUTICALS HOLDINGS, INC. 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA CALIFORNIA 95014 (408) 501-8881 DELAWARE Tenzig Acquisition Corp. Tenzing Acquisition Corp. Corporation true 2018 Laxminarayan Bhat 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Executive Officer Director Narayan Prabhu 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Executive Officer Parag Saxena 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Les Funtleyder 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Richard Margolin 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Purav Patel 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Pharmaceuticals Decline to Disclose 06b false 2022-09-08 false true true true false 0 A.G.P./Alliance Global Partners 8361 None None 88 POST ROAD WEST 2ND FLOOR WESTPORT CT CONNECTICUT 06880 All States false Indefinite 0 Indefinite Value of warrants indeterminable as they were issued in connection with a concurrent registered direct offering of common stock. false 3 0 true 0 true See Item 13. Fees payable to placement agent solely for the issuance of the warrants indeterminable. 0 true false REVIVA PHARMACEUTICALS HOLDINGS, INC. /s/ Laxminarayan Bhat Laxminarayan Bhat President & CEO 2022-09-19